Read time: 1 minute
The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) which serves to advise NAPRA on matters relating to the National Drug Schedules (NDS) program. The primary function of the eight-member committee is to review and analyze submissions regarding scheduling placements for non-prescription drugs and to make recommendations for scheduling.
NDSAC’s members have combined knowledge and experience in various disciplines such as pharmacotherapy, drug utilization, drug interactions, toxicology, pharmacy practice, medical practice, academic research, the drug industry, and pharmaceutical regulatory affairs at federal, provincial, and territorial levels. This knowledge and experience must be relevant to the Canadian public and the Canadian healthcare system.
NAPRA is inviting applications for two vacancies on the NDSAC arising in 2027, including one vacancy for a practising pharmacist with advanced clinical practice experience in a community pharmacy setting, preferably with expertise in nonprescription pharmacotherapy and/or minor ailments prescribing.
For more information about candidate requirements, position details, and the application process, visit the NAPRA website.
Applications must be received no later than September 8, 2026.
